Recent blog posts
The Research and Development Boom is Unstoppable-KRAS G12D Inhibitors
The Research and Development Boom is Unstoppable-KRAS G12D Inhibitors
12 September 2023
KRAS G12D differs from KRAS G12C only in the type of amino acid mutation on the same codon.
Read →
Observations on the Use of CB1 Antagonists in Disease Treatment
Observations on the Use of CB1 Antagonists in Disease Treatment
12 September 2023
The Cannabinoid receptor 1 (CB1), as one of the most classic receptors of the Endocannabinoid system (ECS), is a G protein-coupled membrane receptor.
Read →
Progress in Research on CCR5 Antagonist Drugs
Progress in Research on CCR5 Antagonist Drugs
12 September 2023
CCR5, or C-C chemokine receptor type 5, is a protein receptor found on the surface of certain immune cells, including T cells and macrophages.
Read →
Latest Developments in the Research and Development of CB1 agonists
Latest Developments in the Research and Development of CB1 agonists
12 September 2023
CB1 receptors play a vital role in regulating various physiological processes such as pain perception, appetite, mood, memory, and motor coordination.
Read →
Latest Developments in the Research and Development of C5 Inhibitor
Latest Developments in the Research and Development of C5 Inhibitor
11 September 2023
C5, or the fifth component of complement, plays a crucial role in the human body's immune system.
Read →
BTK inhibitors, a field with promising prospects
BTK inhibitors, a field with promising prospects
11 September 2023
BTK inhibitors can regulate the functions of various immune cells that are crucial to innate and adaptive immune responses.
Read →
Brief Discussion on Clinically Under-Investigation BRD4 Inhibitors
Brief Discussion on Clinically Under-Investigation BRD4 Inhibitors
11 September 2023
BRD4 inhibitors target BRD4 for inhibition, which hold tremendous value in anti-cancer and anti-inflammatory sectors, as well as many other fields.
Read →
Latest Developments in the Research and Development of BET inhibitor
Latest Developments in the Research and Development of BET inhibitor
11 September 2023
BET (Bromodomain and Extra-Terminal) proteins play a crucial role in the regulation of gene expression in the human body.
Read →
Bcl-2 inhibitors show promise for the treatment of various hematological malignancies
Bcl-2 inhibitors show promise for the treatment of various hematological malignancies
11 September 2023
Bcl-2 inhibitors can be used alone to kill cancer cells or can be used in combination with other drugs to increase the sensitivity of cancer cells to drugs.
Read →
Important Target in Synthetic Lethality: ATR Inhibitors
Important Target in Synthetic Lethality: ATR Inhibitors
11 September 2023
The Ataxia telangiectasia and Rad-3 related protein kinase (ATR) is a member of the PIKK protein kinase family, and it is involved in numerous complex DNA damage repair mechanisms.
Read →
Latest Developments in the Research and Development of Angiotensin II Receptor Antagonists
Latest Developments in the Research and Development of Angiotensin II Receptor Antagonists
10 September 2023
The Angiotensin II receptor plays a crucial role in the human body by regulating blood pressure and fluid balance.
Read →
ACE2 - The Human Cell Receptor "Turned Traitor" by COVID-19 Virus
ACE2 - The Human Cell Receptor "Turned Traitor" by COVID-19 Virus
9 September 2023
Angiotensin-converting enzyme 2 (ACE2) is a key enzyme in the Renin-Angiotensin System (RAS), acting as a regulating factor for the ACE-Angiotensin II (Ang II)-Ang receptor I (AT1) axis, maintaining the balance of the RAS system.
Read →